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ABSTRACT: A novel access to spiro[indoline-3,2′-pyrrole]-2,5′-diones is presented via a palladium-catalyzed post-Ugi cascade
cyclization approach involving a Buchwald−Hartwig/Michael reaction sequence. The method allows the easy construction of a
library of spirooxindoles in moderate to good yields starting from readily available precursors. In addition, alkynoic acids are
replaced with α,β-unsaturated acids leading to variably substituted spirooxindoles.
I socyanide based multicomponent reactions (IMCR) withsubsequent post-transformations have been extensively
demonstrated as a powerful method to access new and
privileged heterocyclic scaffolds.1 These reactions are partic-
ularly appealing in terms of molecular diversity, simplicity, and
atom economy along with the ease of using readily available
starting materials. However, the post-IMCR transformations
are generally restricted to a single chemical reaction, thus
limiting the challenge of achieving a high level of structural
complexity. In this context, efforts to develop novel and
selective post-MCR transformations in a domino fashion will
significantly contribute to the advancement of diversity-
oriented synthesis as well as heterocyclic chemistry.2
The ability to access spirocyclic nitrogen-containing hetero-
cycles has always remained a great inspiration for organic
chemists because of their widespread prevalence in nature.3 In
particular, the pyrrolidinyl-spirooxindole framework is present
in a large number of bioactive, naturally occurring alkaloids
such as spiro-tryprostatin B, horsefiline, as well as various
medicinally relevant compounds (Figure 1).4 As a consequence,
efforts have been made to design and develop new methods for
the construction of novel synthetic spirooxindole-fused-hetero-
cycles.5 So far, domino or multicomponent reactions based on
the versatile reactivity of isatin derivatives5,6 have remained the
most prevalent methods for the synthesis of the spirooxindole
framework, while very few methods construct the indole unit
itself.7
Despite these remarkable advances, finding cost-effective and
sustainable synthetic methods to reproduce the structural
diversity and complexity of natural molecules would always be a
welcome addition. Encouraged by the numerous bioactivities of
spiro-oxindoles and in continuation of our endeavor toward the
diversity-oriented synthesis of bioactive heterocyclic molecules
using MCR reactions,2m−o,8 we were interested in designing a
new post-MCR strategy for the synthesis of novel spiroox-
indoles from readily available starting materials. We envisioned
that an efficient and concise one-pot post-Ugi modification
comprising a domino Buchwald−Hartwig/Michael reaction
sequence to obtain spiro[indoline-3,2′-pyrrole]-2,5′-diones
would be highly appealing (Scheme 1).
To test our hypothesis, optimization efforts were initiated by
using the easily accessible N-(1-(2-bromophenyl)-2-(tert-
butylamino)-2-oxoethyl)-N-(4-methoxybenzyl)but-2-ynamide
(1a), obtained via Ugi reaction of o-bromobenzaldehyde, 4-
methoxybenzylamine, tert-butyl isocyanide, and 2-butynoic
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Figure 1. Bioactive compounds containing a spirooxindole framework.
Scheme 1. Retrosynthetic Analysis for Spirooxindoles
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acid, as a substrate in the presence of a Pd catalyst under
various conditions (Table 1). A systematic study revealed that
the catalyst, the ligand, the base, and the temperature exerted a
remarkable influence on the yield of the products (Table 1).
Lower yields were obtained with K2CO3 and K3PO4 (entries 1
and 2) as compared to Cs2CO3 (entry 3), while replacement
with stronger bases such as t-BuONa or t-BuOLi resulted in no
reaction (entries 4 and 5). Also replacement of toluene with
more polar solvents displayed a diminished activity in terms of
yield (entries 6−9). Among the different Pd-catalyst tested,
Pd(OAc)2 was found to be the best (entries 3 and 10−13). The
choice of ligand is critical since only Xantphos was effective for
the aforementioned domino transformation, whereas well-
reported ligands for Buchwald−Hartwig amidation9 or N-
arylation of Ugi adducts like Me-Phos10a or P(o-tol)3
10b were
found to be ineffective (entries 19 and 20). Moreover, both
DPEphos and dppf, which are also bidentate ligands and have
similar bite angles as Xantphos, did not turn out to be that
active. This emphasizes the importance of the flexible
coordination environment of the Xantphos backbone to
promote this domino sequence effectively.11 It was also
observed that the reaction was occurring in a cascade manner
and in the absence of catalyst or ligand or base resulted in no
product yield (Table S2, Supporting Information).
Further efforts to increase the yield by varying the reaction
time or temperature were not successful (entries 21−23). We
concluded that the best conditions are Pd(OAc)2 (5 mol %),
Xantphos (7.5 mol %), and Cs2CO3 (2 equiv) in toluene at 120
°C for 24 h, allowing the above domino reaction to occur
smoothly providing the spirooxindole 2a in 75% isolated yield
(Table 1, entry 3). With the optimized reaction conditions in
hand, we evaluated the scope and limitations of the process
(Table 2). Initially, the influence of the haloaldehyde subunit
on the reaction outcome was examined. Whereas the o-
iodobenzaldehyde afforded 2a in 80% yield, the o-chloroben-
zaldehyde led to a significant decrease in the reaction yield
(entries 1 and 2). As illustrated in Table 2, electron-donating or
electron-withdrawing groups on the aryl ring were well
tolerated. Also, substrates bearing ortho, meta, or para
substituents provided the corresponding products in moder-
Table 1. Optimization of Reaction Conditionsa
aReaction conditions: all reactions were performed with 1a (0.2
mmol), catalyst (5 mol %), ligand (7.5 mol %), and base (0.4 mmol)
in solvent (2.0 mL) at different temperatures for 24 h. bYields based
on 1H NMR. isolated yield in parentheses. nd = not detected.
Table 2. Scope of the Developed Domino Buchwald−
Hartwig/Michael Processa
aReaction conditions: all reactions were performed with Ugi substrate
(0.2 mmol), Pd(OAc)2 (5 mol %), Xantphos (7.5 mol %) and Cs2CO3
(0.4 mmol) in toluene (2.0 mL) at 120 °C for 24 h. bIsolated yield; nd
= not detected. PMB = p-methoxybenzyl.
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ate-to-good yields. The reaction worked well with aliphatic but
not with aromatic isonitriles (entry 12). In addition, the Ugi
adduct derived from propiolic acid failed to give the desired
spirocycle (entry 20).
Mechanistically, two new chemical bonds are formed in the
present process, involving a Buchwald−Hartwig amidation (C−
N bond) and Michael addition (C−C bond) sequence.
Although it was reasonable to assume that two bonds were
formed sequentially and the aryl-amidation preceded the base-
catalyzed Michael addition, more convincing support was
sought. Our attempts to carry out the reactions in a sequential
manner, i.e., first the base-catalyzed Michael addition from the
active methine12 and then a Buchwald−Hartwig amidation or
reverse proved to be futile. Thus, the involvement of a
palladacycle in the intramolecular Michael addition13 could not
be ruled out with certainty. Moreover, our attempts to stop the
reaction after intermolecular N-arylation failed. Our assumption
that the second step of the reaction is simply a base-catalyzed
nucleophilic addition reaction was ascertained when 2-alkynoic
acid was replaced with benzoic acid or 2-fluorobenzoic acid,
resulting in the desired product in traces and 90% yield,
respectively (see the Supporting Information, Scheme S1).
Based on these observations and previous reports,10,12 we
hypothesized a reaction mechanism which is outlined in
Scheme 2. The first step is the oxidative addition of the Pd(0)
catalyst to 1a leading to palladium complex A. Thereafter, the
base-catalyzed deprotonation of the amide and its co-ordination
to the Pd(II) species results in the formation of a six-membered
palladacycle B. This is followed by reductive elimination giving
intermediate C. The next step involves the base-catalyzed
Michael addition leading to the final product 2a. The activation
of this Csp3−H proton by base is well documented in the
literature regarding C-arylations.12a To further shed light on the
reaction mechanism, we performed a deuterium-labeling
experiment on the tandem Buchwald−Hartwig/Michael
addition sequence of the Ugi adduct 1a in the presence of
Pd(OAc)2, Xantphos, and Cs2CO3 with up to 3 equiv of
deuterated methanol in toluene. According to the NMR
spectra, the deuterium was located on the endocyclic double
bond of the pyrrole ring (Table 3, entry 1). Further, it was
ascertained that the use of 2-alkynoic acids was necessary to
ensure the occurrence of this domino reaction as substitution
with 3-alkynoic acid (Table 3, entry 2) failed to produce the
desired spirocycle. Furthermore, use of α,β-unsaturated acids
instead of 2-alkynoic acids resulted in good yields with
adequate diastereoselectivity (Table 3, entries 3 and 4).
In summary, we have devised a highly efficient methodology
for the synthesis of the spiro[indoline-3,2′-pyrrole]-2,5′-dione
framework via a Pd(0)-catalyzed domino Buchwald−Hartwig/
Michael reaction sequence. The protocol works equally well
when alkynoic acids are replaced with α,β-unsaturated acids
(such as cinnamic acids or atropic acid) leading to diversely
substituted spirooxindoles. The operational simplicity together
with the synthetic efficiency of the protocol will be beneficial
for academic and industrial research toward the synthesis of
druglike small molecules with enhanced structural diversity and
molecular complexity. Further studies on the reaction scope
and the expansion of the synthetic applications of the above
methodology are under current investigation.
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